Thursday, March 3, 2016

Big Pharma: The Business of Innovation and Regulation with Luba Greenwood

Pharmaceutical companies have come under increasing scrutiny for large increases in drug prices over the past years. Some have blamed investors and M&A for pressuring companies to raise prices. Others have blamed a broken patent and regulatory framework that stymies effective competition.

In this talk, Luba Greenwood will explore the role of incentives, regulation, investment, and the patent system in driving the business model of modern pharma, and the ultimate impact of this system on patients.

5:00 p.m. reception
5:30 p.m. lecture

Harper Center Room C25
5807 S Woodlawn Ave
Chicago, IL 60637

Free and open to the public

Register »


Support The Stigler Center
Pro-Market | The Stigler Center Blog
Financial Trust Index, How much do Americans trust financial institutions?
Sign Up for the Stigler Newsletter

Connect

Twitter

Facebook